NYLIM
RVMD icon

New York Life Investment Management’s Revolution Medicines RVMD Stock Holding History

New York Life Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
23,449
+367
+2% +$53.6K 0.03% 375
2026
Q1 		$2.24M Buy
23,082
+7,382
+47% +$745K 0.02% 521
2025
Q4 		$1.25M Sell
15,700
-2,209
-12% -$145K 0.01% 575
2025
Q3 		$836K Sell
17,909
-543
-3% -$21.3K 0.01% 692
2025
Q2 		$679K Sell
18,452
-312
-2% -$12K 0.01% 715
2025
Q1 		$663K Buy
+18,764
New +$762K 0.01% 727
2024
Q4 		– Sell
-17,791
Closed -$807K – 861
2024
Q3 		$807K Buy
+17,791
New +$775K 0.01% 736

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

New York Life Investment Management's RVMD Position: Q2 2026 in Review

New York Life Investment Management increased its Revolution Medicines (RVMD) stake by 1.6% in Q2 2026, buying an estimated $53.6K and bringing the position to 23,449 shares worth $4.39M. The position accounts for 0.03% of the portfolio, ranked #375.

New York Life Investment Management first reported a position in RVMD in Q3 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • New York Life Investment Management held 23,449 shares of Revolution Medicines worth $4.39M as of Q2 2026.
  • New York Life Investment Management bought 367 Revolution Medicines shares in Q2 2026, an estimated $53.6K.
  • Revolution Medicines made up 0.03% of New York Life Investment Management's portfolio in Q2 2026, its #375 holding.
  • New York Life Investment Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.